More recently, the effects of the immunosuppressive treatment over a IgD- CD27- B cell subpopulation (double negative; DN) were documented in SLE patients with kidney damage, demonstrating a decreased frequency of these cells in patients who responded to therapy (26). This evidence concerns the gene CD27 and systemic lupus erythematosus.